ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #4,619Hybrid

Cancer Epidemiology

Acronym:canep
•
Abbreviation (ISO):CANCER EPIDEMIOL
•
Identifier (ISSN):1877-7821(Print)/1877-783X(Online)
•
Publisher:Elsevier BV
Clarivate IF (2026)
3↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Epidemiology

WoS Q3
12342.8920182.6220192.1820202.9820212.8920222.620232.420242.3202532026
Annual Impact Factor Metric
Current (2026):3
Scopus SJR & RankScopus Q2
1.036
#4,619

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
94

94 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate4.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
144articles/year
39.21% Gold OA•93.25% Original Research

Aims & Scope

Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: • Descriptive epidemiology • Studies of risk factors for disease initiation, development and prognosis • Screening and early detection • Prevention and control • Methodological issues The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.

Topics Covered (Recognized by AI)
Medicine99.5%Internal medicine88.5%Biology88%Genetics82.6%Cancer74.4%Pathology73%Mathematics65.2%Sociology59.7%Demography58.5%Environmental health54.8%Statistics51.9%Population51.5%Surgery36%Oncology34.4%Epidemiology29.9%Physics29%Confidence interval27.2%Chemistry26.2%Computer science24.6%Geometry24.5%Optics24.4%Incidence (geometry)23.9%Biochemistry23.9%Cancer registry21.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q3
Rank172/333
IndexSCIE
JCRSCIE2026

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q2
Rank133/443
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank144/333
IndexSCIE
JCISCIE2026

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q2
Rank200/443
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3
Articles / Year215
Total Citations57
2025
IF2.3
Articles / Year202
Total Citations424
2024
IF2.4
Articles / Year179
Total Citations1,258
2023
IF2.6
Articles / Year156
Total Citations1,224
2022
IF2.89
Articles / Year194
Total Citations2,049

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,619Scopus Q2SCImago Profile
Scopus Coverage:2009-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
1.036

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.14

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,381 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,530
3-Year Documents487
Citable Documents469

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate48.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ2
EpidemiologyQ2
OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Epidemiology (acronym: canep, abbr: CANCER EPIDEMIOL, ISSN: 1877-7821) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier BV in England since 2009. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.036 (Q2), an H-index of 94.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 144 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,381 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier BV
Publication Language
English
Frequency
Bimonthly
Founding Year
2009
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c0e61d53-ff74-453a-92df-8eb64a2e959c
Database Updated: 2026-10-01